{"id":17139,"date":"2022-10-04T12:55:28","date_gmt":"2022-10-04T12:55:28","guid":{"rendered":"https:\/\/admin.acceleratingscience.com\/behindthebench\/?p=17139"},"modified":"2026-04-06T19:47:57","modified_gmt":"2026-04-06T19:47:57","slug":"can-liquid-biopsy-redefine-cancer-management","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/","title":{"rendered":"Can Liquid Biopsy Redefine Cancer Management?"},"content":{"rendered":"<h2 style=\"font-size: 26px\">dPCR and Effective Use of Liquid Biopsy in Cancer Diagnosis<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-17146 size-large\" style=\"background-color: #fff\" title=\"Applied Biosystems QuantStudio Absolute Q Digital PCR for Effective Use of Liquid Biopsy in Cancer Diagnosis and Management\" src=\"http:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-1-1024x683.jpg\" alt=\"Two scientists looking at Applied Biosystems QuantStudio Absolute Q Digital PCR System.\" width=\"760\" height=\"507\" srcset=\"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-1-1024x683.jpg 1024w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-1-300x200.jpg 300w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-1-768x512.jpg 768w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-1-96x65.jpg 96w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-1.jpg 1430w\" sizes=\"auto, (max-width: 760px) 100vw, 760px\" \/>The spotlight on liquid biopsy is getting brighter. Technologies such as next generation sequencing (NGS) and digital PCR (dPCR) combined with the continual quest of cancer researchers like Dr. Atocha Romero are allowing us to determine potentially effective use of liquid biopsy in cancer diagnosis and management.<\/p>\n<p>Atocha heads the Liquid Biopsy Laboratory (LBL) at Hospital Universitario Puerta de Hierro in Madrid, Spain. Her lab focuses on biomarker discovery and performs liquid-biopsy-based non-invasive biomarker testing for subjects with lung and other cancers.<\/p>\n<p>Our Senior Marketing Manager, Dr. Deepak Tripathi, interviewed Atocha to learn about the challenges she faces in the field and how she attempts to solve them.<\/p>\n<h3>Conversation with Dr. Atocha Romero<\/h3>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: You have been working in the translational cancer field for a very long time. What motivates you to fight cancer? Why did you choose oncology research?<\/span><\/p>\n<p><strong>A<\/strong>: Cancer is very prevalent, so I was always interested in fighting against it. As a pharmacist, I wanted to study molecular biology as it is very relevant in the oncology field.<\/p>\n<p>The development of targeted therapies has significantly improved survival in patients, mostly due to advances in molecular biology. I see its positive impact on patients every day. This pushes us to keep going.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: What questions are you trying to answer with your research?<\/span><\/p>\n<p><strong>A<\/strong>: We are trying to analyze the clinical utility of liquid biopsy in cancer, mostly for lung cancer patients. Liquid biopsy is useful for non-invasive biomarker testing, especially in patients with lung cancer because lung cancer tissue is difficult to access.<\/p>\n<p>Besides, lung cancer is often diagnosed at an advanced age. Therefore, we want to know if liquid biopsy can be used to monitor disease and guide clinical decision-making.<\/p>\n<p>We are also exploring the clinical utility of liquid biopsy in the context of neoadjuvant clinical trials. Neoadjuvant therapies are given to patients before they go into surgery. We are asking if we can use liquid biopsy to evaluate the efficacy of neoadjuvant treatments. This is very important because we need early endpoints that correlate with long-term survival and that can be measured faster than overall survival. This way we can speed up the process of such clinical trials.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: What challenges do you face in delivering patient care in translational medicine and how have Applied Biosystems technologies helped you?<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-17144 size-medium\" style=\"margin-right: 25px!important;background-color: #fff\" title=\"Powerfully simple digital PCR technology\" src=\"http:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-2-300x200.jpg\" alt=\"Three scientists working together in laboratory.\" width=\"300\" height=\"200\" srcset=\"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-2-300x200.jpg 300w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-2-96x65.jpg 96w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-2.jpg 728w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><strong>A<\/strong>: One of the challenges we face is the incorporation of NGS in the clinical setting. In Spain, it&#8217;s taking a while to incorporate NGS for the diagnosis of cancer patients, but we need to go for it. One of the reasons for this delay could be that many pathologists are not yet used to such technologies.<\/p>\n<p>I believe more information in the form of educational webinars and events from Applied Biosystems could help them incorporate new technologies and ways of analysis for the management of cancer patients within clinical research.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: What are the benefits of using qPCR and dPCR in translational cancer research over NGS and other technologies?<\/span><\/p>\n<p><strong>A<\/strong>: NGS has proved itself as a very useful technology for biomarker testing in solid tumor biopsy. It is recommended, particularly for lung cancer patients, where there are a lot of targeted therapies available.<\/p>\n<p>Digital PCR is very useful to monitor disease progression. We use dPCR to monitor mutations. For example, when the tumor of a patient has a druggable mutation, monitoring that mutation over the course of the treatment is very helpful because, together with the imaging information, dPCR monitoring enables us to narrow down strategies for patient management.<\/p>\n<p>Also, dPCR is cheaper than NGS. In our institution, we can get it done for less than 15 Euros per sample. It&#8217;s very informative and enables more accurate management of patients that participate in our studies.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: What are your thoughts on using multi-omics approaches to identify new targets and biomarkers, especially while dealing with more procedure-oriented treatments?<\/span><\/p>\n<p><strong>A<\/strong>: I believe multi-omics approaches are going to improve the diagnosis of cancer patients, especially in lung cancer where there are a lot of approved and upcoming targeted therapies.<\/p>\n<p>Multi-omics approaches enable more efficient management of tissue samples, thereby opening up more possibilities for the treatment of patients.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: To what extent does liquid biopsy compliment radiographic imaging in the detection of early recurrence of definitively treated lung cancer? What is your opinion as an expert in liquid biopsy?<\/span><\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-17145 size-medium alignleft\" style=\"margin-left: 0!important;background-color: #fff\" title=\"Complete assay solutions for dPCR applications\" src=\"http:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3-300x200.jpg\" alt=\"Scientists working in lab preparing assays.\" width=\"300\" height=\"200\" srcset=\"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3-300x200.jpg 300w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3-96x65.jpg 96w, https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg 674w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>A<\/strong>: Liquid biopsy can complement imaging data. So sometimes there is inflammation surrounding the tumor and that would be a confounding factor because you may think the tumor is growing, where it is not. So in this case, liquid biopsy can help.<\/p>\n<p>Also, during screening, combining information from liquid biopsy with imaging data can help reduce false positives. This way we can avoid unnecessary invasive follow-up biopsies.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: Any thoughts on tumor mutational burden (TMB) and microsatellite instability (MSI) in blood as biomarkers for immunotherapy?<\/span><\/p>\n<p><strong>A<\/strong>: TMB is a promising predictive biomarker for immunotherapy. The challenge we face with TMB is clonal hematopoiesis.<\/p>\n<p>Clonal hematopoiesis refers to non-malignant mutations in blood cells. It becomes frequent with age. So, as we get older, we accumulate mutations, also in blood cells, which can interfere with using TMB as a biomarker. Therefore, we need mechanisms to filter out mutations from clonal hematopoiesis to accurately estimate TMB in blood.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: Which molecular targets are of particular interest to you?<\/span><\/p>\n<p><strong>A<\/strong>: We focus on molecular targets with approved therapies, such as EGFR and ALK. We do intense research in ALK testing using liquid biopsies because patients with ALK rearrangements are more difficult to detect than a SNP and we are researching on which way yields better results and higher positivity rate using liquid biopsy to test this alteration for these patients.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #2f5496;font-weight: bold\">Q: What is your message to early-career young scientists who are starting their journey in the research field?<\/span><\/p>\n<p><strong>A<\/strong>: My recommendation to young scientists is that they should follow what they like and pursue their goals. Science is sometimes difficult, but in the end, you will get the results if you don&#8217;t give up. So, do not give up on your dreams!<\/p>\n<p>&nbsp;<\/p>\n<p>&#8212;\u00a0<em>This interview has been edited for length and clarity.<\/em><\/p>\n<p>&nbsp;<\/p>\n<h2>Learn More About dPCR and Other Advanced Technologies for Cancer Research<\/h2>\n<h3><a title=\"Applied Biosystems Solutions for Cancer Research\" href=\"https:\/\/www.thermofisher.com\/us\/en\/home\/brands\/applied-biosystems\/cancer-research.html\" target=\"_blank\" rel=\"noopener\">\u00bb Applied Biosystems Solutions for Cancer Research<\/a><\/h3>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>dPCR and Effective Use of Liquid Biopsy in Cancer Diagnosis The spotlight on liquid biopsy is getting brighter. Technologies such as next generation sequencing (NGS) and digital PCR (dPCR) combined with the continual quest of cancer researchers like Dr. Atocha Romero are allowing us to determine potentially effective use of liquid biopsy in cancer diagnosis<\/p>\n","protected":false},"author":120,"featured_media":17145,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_monsterinsights_skip_tracking":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[54,172],"tags":[1844,57,2278,119,20],"division":[],"class_list":["post-17139","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cancer-research","category-general","tag-cancer-research","tag-digital-pcr","tag-dpcr","tag-liquid-biopsy","tag-qpcr","entry"],"_selected_authors":[],"_selected_reviewers":[1486],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.9 (Yoast SEO v28.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>dPCR and Liquid Biopsy in Cancer Diagnosis and Management<\/title>\n<meta name=\"description\" content=\"Technologies such digital PCR (dPCR) are allowing researchers to determine potentially effective use of liquid biopsy in cancer diagnosis and management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Can Liquid Biopsy Redefine Cancer Management?\" \/>\n<meta property=\"og:description\" content=\"Technologies such digital PCR (dPCR) are allowing researchers to determine potentially effective use of liquid biopsy in cancer diagnosis and management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/\" \/>\n<meta property=\"og:site_name\" content=\"Behind the Bench\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thermofisher\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T12:55:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-06T19:47:57+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"674\" \/>\n\t<meta property=\"og:image:height\" content=\"449\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Behind The Bench Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:site\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Behind The Bench Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/\"},\"author\":{\"name\":\"Behind The Bench Staff\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/7c9eade775fde6f2d8b4160ac5cc3bae\"},\"headline\":\"Can Liquid Biopsy Redefine Cancer Management?\",\"datePublished\":\"2022-10-04T12:55:28+00:00\",\"dateModified\":\"2026-04-06T19:47:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/\"},\"wordCount\":1066,\"commentCount\":1,\"image\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2022\\\/10\\\/scientists-lab-3.jpg\",\"keywords\":[\"cancer research\",\"digital PCR\",\"dpcr\",\"liquid biopsy\",\"qPCR\"],\"articleSection\":[\"Cancer Research\",\"General\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/\",\"url\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/\",\"name\":\"dPCR and Liquid Biopsy in Cancer Diagnosis and Management\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2022\\\/10\\\/scientists-lab-3.jpg\",\"datePublished\":\"2022-10-04T12:55:28+00:00\",\"dateModified\":\"2026-04-06T19:47:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/7c9eade775fde6f2d8b4160ac5cc3bae\"},\"description\":\"Technologies such digital PCR (dPCR) are allowing researchers to determine potentially effective use of liquid biopsy in cancer diagnosis and management.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2022\\\/10\\\/scientists-lab-3.jpg\",\"contentUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2022\\\/10\\\/scientists-lab-3.jpg\",\"width\":674,\"height\":449,\"caption\":\"Scientists working in lab.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/can-liquid-biopsy-redefine-cancer-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Can Liquid Biopsy Redefine Cancer Management?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\",\"name\":\"Behind the Bench\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/7c9eade775fde6f2d8b4160ac5cc3bae\",\"name\":\"Behind The Bench Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g\",\"caption\":\"Behind The Bench Staff\"},\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/author\\\/behind-the-bench-staff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"dPCR and Liquid Biopsy in Cancer Diagnosis and Management","description":"Technologies such digital PCR (dPCR) are allowing researchers to determine potentially effective use of liquid biopsy in cancer diagnosis and management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/","og_locale":"en_US","og_type":"article","og_title":"Can Liquid Biopsy Redefine Cancer Management?","og_description":"Technologies such digital PCR (dPCR) are allowing researchers to determine potentially effective use of liquid biopsy in cancer diagnosis and management.","og_url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/","og_site_name":"Behind the Bench","article_publisher":"https:\/\/www.facebook.com\/thermofisher","article_published_time":"2022-10-04T12:55:28+00:00","article_modified_time":"2026-04-06T19:47:57+00:00","og_image":[{"width":674,"height":449,"url":"http:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg","type":"image\/jpeg"}],"author":"Behind The Bench Staff","twitter_card":"summary_large_image","twitter_creator":"@thermofisher","twitter_site":"@thermofisher","twitter_misc":{"Written by":"Behind The Bench Staff","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#article","isPartOf":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/"},"author":{"name":"Behind The Bench Staff","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/7c9eade775fde6f2d8b4160ac5cc3bae"},"headline":"Can Liquid Biopsy Redefine Cancer Management?","datePublished":"2022-10-04T12:55:28+00:00","dateModified":"2026-04-06T19:47:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/"},"wordCount":1066,"commentCount":1,"image":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg","keywords":["cancer research","digital PCR","dpcr","liquid biopsy","qPCR"],"articleSection":["Cancer Research","General"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/","url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/","name":"dPCR and Liquid Biopsy in Cancer Diagnosis and Management","isPartOf":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#primaryimage"},"image":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg","datePublished":"2022-10-04T12:55:28+00:00","dateModified":"2026-04-06T19:47:57+00:00","author":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/7c9eade775fde6f2d8b4160ac5cc3bae"},"description":"Technologies such digital PCR (dPCR) are allowing researchers to determine potentially effective use of liquid biopsy in cancer diagnosis and management.","breadcrumb":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#primaryimage","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg","contentUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg","width":674,"height":449,"caption":"Scientists working in lab."},{"@type":"BreadcrumbList","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/can-liquid-biopsy-redefine-cancer-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admin.acceleratingscience.com\/behindthebench\/"},{"@type":"ListItem","position":2,"name":"Can Liquid Biopsy Redefine Cancer Management?"}]},{"@type":"WebSite","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/","name":"Behind the Bench","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.acceleratingscience.com\/behindthebench\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/7c9eade775fde6f2d8b4160ac5cc3bae","name":"Behind The Bench Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g","caption":"Behind The Bench Staff"},"url":"https:\/\/admin.acceleratingscience.com\/author\/behind-the-bench-staff\/"}]}},"taxonomy_info":{"category":[{"value":54,"label":"Cancer Research"},{"value":172,"label":"General"}],"post_tag":[{"value":1844,"label":"cancer research"},{"value":57,"label":"digital PCR"},{"value":2278,"label":"dpcr"},{"value":119,"label":"liquid biopsy"},{"value":20,"label":"qPCR"}]},"featured_image_src_large":["https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg",674,449,false],"author_info":{"display_name":"Behind The Bench Staff","author_link":"https:\/\/admin.acceleratingscience.com\/author\/behind-the-bench-staff\/"},"comment_info":1,"category_info":[{"term_id":54,"name":"Cancer Research","slug":"cancer-research","term_group":0,"term_taxonomy_id":54,"taxonomy":"category","description":"","parent":0,"count":143,"filter":"raw","meta":[],"cat_ID":54,"category_count":143,"category_description":"","cat_name":"Cancer Research","category_nicename":"cancer-research","category_parent":0},{"term_id":172,"name":"General","slug":"general","term_group":0,"term_taxonomy_id":172,"taxonomy":"category","description":"","parent":0,"count":162,"filter":"raw","meta":[],"cat_ID":172,"category_count":162,"category_description":"","cat_name":"General","category_nicename":"general","category_parent":0}],"tag_info":[{"term_id":1844,"name":"cancer research","slug":"cancer-research","term_group":0,"term_taxonomy_id":1844,"taxonomy":"post_tag","description":"","parent":0,"count":22,"filter":"raw","meta":[]},{"term_id":57,"name":"digital PCR","slug":"digital-pcr","term_group":0,"term_taxonomy_id":57,"taxonomy":"post_tag","description":"","parent":0,"count":51,"filter":"raw","meta":[]},{"term_id":2278,"name":"dpcr","slug":"dpcr","term_group":0,"term_taxonomy_id":2278,"taxonomy":"post_tag","description":"","parent":0,"count":16,"filter":"raw","meta":[]},{"term_id":119,"name":"liquid biopsy","slug":"liquid-biopsy","term_group":0,"term_taxonomy_id":119,"taxonomy":"post_tag","description":"","parent":0,"count":14,"filter":"raw","meta":[]},{"term_id":20,"name":"qPCR","slug":"qpcr","term_group":0,"term_taxonomy_id":20,"taxonomy":"post_tag","description":"","parent":0,"count":37,"filter":"raw","meta":[]}],"jetpack-related-posts":[{"id":19579,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/liquid-biopsy-cancer-research-ngs-pcr\/","url_meta":{"origin":17139,"position":0},"title":"From Discovery to Monitoring: How Sequencing and PCR Work Together in Oncology Research","author":"Behind The Bench Staff","date":"March 24, 2026","format":false,"excerpt":"Scientific, joins the Absolute Gene-ius podcast to discuss how molecular technologies are advancing precision oncology research. With experience spanning clinical laboratory research, digital PCR research applications, and next-generation sequencing (NGS), Dr. Sollweck shares how scientists are addressing critical unmet needs in cancer research. From liquid biopsy research strategies to minimal\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Sollweck-headshot-200x250_Jordan-Ruggieri.jpeg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":20019,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/qpcr-dpcr-ngs-cancer-research\/","url_meta":{"origin":17139,"position":1},"title":"From tumor heterogeneity to low-frequency variants: How qPCR, dPCR, and NGS work together in cancer research","author":"Ashleigh Barlow","date":"September 26, 2026","format":false,"excerpt":"Dr. Javier Hernandez Losa explains how combining broad genomic profiling with targeted, sensitive confirmation can help researchers address some of cancer biology\u2019s most difficult analytical challenges. A Q&A with Dr. Javier Hernandez Losa, Director of the Molecular Biology Laboratory, Department of Pathology, Hospital Universitario Vall d\u2019Hebron, Barcelona Cancer research increasingly\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Dr. Javier Hernandez Losa, Director of the Molecular Biology Laboratory at Hospital Universitario Vall d'Hebron in Barcelona.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/Picture133.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/Picture133.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/Picture133.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/Picture133.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/Picture133.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":19805,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/liquid-biopsy-workflow-standardization\/","url_meta":{"origin":17139,"position":2},"title":"Improving the Reliability of Liquid Biopsy in Real-World Settings Through Workflow Standardization: A Discussion with Dr. Matteo Allegretti","author":"Ashleigh Barlow","date":"June 18, 2026","format":false,"excerpt":"Liquid biopsy offers a powerful, noninvasive way to detect and track cancer, but ensuring reliability in real-world settings remains a key hurdle. Variability in workflows and the need for robust verification steps limit widespread adoption. Dr. Matteo Allegretti, Senior Researcher at the Translational Oncology Research Unit at the IRCCS Regina\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Research scientist operating laboratory equipment during liquid biopsy and biomarker research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":19345,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/precision-oncology-diagnostics\/","url_meta":{"origin":17139,"position":3},"title":"The Expanding Role of Molecular Diagnostics in Precision Oncology","author":"Behind The Bench Staff","date":"January 13, 2026","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=F6FfHIizJBY For Dr. Harald Bartsch, a clinical pathologist in southern Bavaria, molecular diagnostic tools have become an indispensable part of his arsenal. \u201cI believe molecular diagnostics play a crucial role in modern oncology, and I see this as the direction everything is headed,\u201d says Dr. Bartsch. While immunohistochemistry remains central\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Clinical Pathologist in a Molecular Diagnostics Laboratory","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19911,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/multiplex-mirna-profiling-precision-oncology\/","url_meta":{"origin":17139,"position":4},"title":"A scalable multiplex miRNA profiling workflow for precision oncology research","author":"Ashleigh Barlow","date":"August 18, 2026","format":false,"excerpt":"The promise of precision oncology rests on our ability to reliably monitor tumor biology in real time. Circulating microRNAs (miRNAs) offer that opportunity, serving as potentially stable, non-invasive biomarkers linked to disease progression and therapeutic response; however, their adoption in routine practice remains constrained by technical hurdles. (1,2) Because cancer\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Scientist pipetting a laboratory sample during molecular biomarker research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19232,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/early-molecular-relapse-detection-dpcr\/","url_meta":{"origin":17139,"position":5},"title":"Following the Molecular Fingerprints of Cancer with Digital PCR","author":"Behind The Bench Staff","date":"November 11, 2025","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=vbta1TG617s For clinical researchers and scientists, the value of a biomarker depends on its accurate measurement and trackability over time. Digital PCR (dPCR) delivers both. At Tata Medical Center, Dr. Mayur Parihar, Senior Consultant in Hematology and Cytogenetics and Clinical Research Scientist at the Tata Translational Cancer Research Center, recognizes\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Pathologist preparing a molecular diagnostic sample in a clinical laboratory to support precision oncology decision-making.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2022\/10\/scientists-lab-3.jpg","_links":{"self":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/17139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/users\/120"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/comments?post=17139"}],"version-history":[{"count":0,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/17139\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media\/17145"}],"wp:attachment":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media?parent=17139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/categories?post=17139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/tags?post=17139"},{"taxonomy":"division","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/division?post=17139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}